openPR Logo
Press release

LifeTein Awarded the Fastest Peptide Synthesis Service in 2021

01-06-2022 10:06 AM CET | Science & Education

Press release from: LifeTein

Fastest Peptide Synthesis Service in 2021

Fastest Peptide Synthesis Service in 2021

LifeTein is a contract research organization located in Somerset, New Jersey and was founded in 2008. Regarded as the fastest peptide synthesis service in 2021 by New World Report, LifeTein also provides custom protein, antibody, and chemical services for biotech, pharma, academia, government customers, and diagnostics. Additionally, its services reach across the entire United States and more than 30 other nations.

New World Report is an informative business news platform that covers businesses all throughout the Americas. Each year they honor the best of the best in their North America Business Elite awards, acknowledging the talent and accomplishments in businesses from any scale or field. Being recognized as the Fastest Peptide Synthesis Service is a tremendous honor for LifeTein.

The chemical synthesis of very long peptides is particularly challenging; the process is expensive and time-consuming. LifeTein is asked frequently to synthesize relatively large peptides sized 100–200 residues. Li Li explains, “Recently, we synthesized a 169-amino acid peptide. This demonstrates that the synthesis of peptides sized 100–200 amino acids is not beyond the capabilities of our current PeptideSyn technology.” LifeTein’s primary focus is peptide synthesis service. The company has developed proprietary PeptideSyn technology, which provides a platform for continuous peptide synthesis using Fmoc and Boc chemistry, microwave technology, and a proprietary solid support resin. LifeTein routinely uses proprietary microwave technologies to produce peptides >100 amino acids, with the longest peptide it has made to date being 169 amino acids. The company takes great pride in this acknowledgement of the speed of its peptide synthesis as well.

LifeTein’s PNA synthesis service is another stand-out service of the company. PNAs are synthetic DNA, or RNA, mimics that consist of nucleobases attached to a polyamide
backbone. PNA provides a powerful tool to study the mechanism of transcription and an innovative strategy to regulate target gene expression, antisense, antigen agents, molecular probes, and biosensors.

LifeTein also provides peptide design and antibody production services; recently, it has synthesized the Receptor Binding Domain (RBD) of the spike protein of the COVID-19 virus. As a result, the RBD peptide was used for monoclonal antibody production and the antibody was successfully made and licensed to a reputable pharmaceutical company.

With LifeTein leading the way within this industry, you can expect them to continue the path of innovation at the same high quality it has always given.

LifeTein LLC,
100 Randolph Rd, Suite 2D, Somerset, NJ 08873

LifeTein is a contract research organization located in Somerset, New Jersey and was founded in 2008. LifeTein provides custom peptide, protein, antibody, and chemical services for biotech, pharma, academia, government customers, and diagnostics.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release LifeTein Awarded the Fastest Peptide Synthesis Service in 2021 here

News-ID: 2518406 • Views:

More Releases for Peptide

Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be? In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights: • Global Peptide Cancer Drug Market Insight By Region & Indication • Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion • Approved Peptide Cancer Drugs: > 30 Drugs • Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis • Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase • Insight On Peptide Cancer Drugs In Clinical Trials: >
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). [https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established